KOVEN ANDREW I 4
4 · KALA BIO, Inc. · Filed Jun 17, 2025
Insider Transaction Report
Form 4
KALA BIO, Inc.KALA
KOVEN ANDREW I
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-15+6,850→ 6,850 totalExercise: $4.30Exp: 2035-06-14→ Common Stock (6,850 underlying) - Award
Common Stock
2025-06-15+3,050→ 16,972 total
Footnotes (3)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 15, 2026 or (ii) the date of the first annual meeting of stockholders occurring in 2026.
- [F2]Includes 8,061 unvested RSUs.
- [F3]This option was granted on June 15, 2025 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 15, 2026 or (ii) the date of the first annual meeting of stockholders occurring in 2026.